Anti Microbial Peptides Global Market Report 2025

Description

Antimicrobial peptides (AMPs) are short proteins that play a vital role in the immune system by defending against bacteria, viruses, fungi, and parasites. They function by disrupting the cell membranes of pathogens, leading to their destruction. AMPs are naturally produced by a wide range of organisms, including humans, animals, and plants, and are being investigated as potential alternatives to traditional antibiotics due to their broad-spectrum antimicrobial activity.

The main types of antimicrobial peptides include plant antimicrobial peptides, bacterial antimicrobial peptides, animal antimicrobial peptides, and insect antimicrobial peptides. Plant antimicrobial peptides are small proteins produced by plants to protect against pathogens such as bacteria, fungi, and viruses. These peptides can address various ailments including pneumonia, hepatitis, bacterial infections, and HIV. They can be administered through different routes, such as topical, subcutaneous, and intravenous. Antimicrobial peptides are distributed through various channels including hospitals, research institutes, specialty clinics, pharmacies, and are used by sectors such as pharmaceuticals and healthcare, agriculture, and biological engineering.

The antimicrobial peptides market research report is one of a series of new reports from The Business Research Company that provides antimicrobial peptides market statistics, including antimicrobial peptides industry global market size, regional shares, competitors with an antimicrobial peptides market share, detailed antimicrobial peptides market segments, market trends and opportunities, and any further data you may need to thrive in the antimicrobial peptides industry. This antimicrobial peptides market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The anti microbial peptides market size has grown strongly in recent years. It will grow from $6.49 billion in 2024 to $7.03 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to the rising prevalence of antibiotic-resistant infections, increasing demand for novel antimicrobial therapies, growing concerns over the efficacy of traditional antibiotics, and expansion of research funding for antimicrobial drug discovery.

The anti microbial peptides market size is expected to see strong growth in the next few years. It will grow to $9.63 billion in 2029 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to rising demand in healthcare, regulatory approvals, growing investment in peptide-based drug development, rising focus on antimicrobial resistance mitigation, and advancements in peptide synthesis and delivery technologies. Major trends in the forecast period include technological advancements, innovative therapeutics, biotechnology techniques, research and development, development of engineered peptides, and advancements in biotechnology.

The rising incidence of infectious diseases is anticipated to drive the growth of the antimicrobial peptide market. Infectious diseases, caused by harmful organisms such as bacteria, viruses, fungi, or parasites, are increasing due to factors such as climate change, the emergence of drug-resistant pathogens, and poor dietary habits. Antimicrobial peptides present a promising solution for these issues, offering new therapeutic options that address the challenges of antibiotic resistance and the limitations of traditional treatments. For example, in October 2023, the UK public sector information website Gov.uk reported that England saw 3,805 new HIV diagnoses in 2022, a 22% increase from the 3,118 cases in 2021 and a 26% rise from the 3,026 cases in 2020. This surge in infectious diseases is fueling the growth of the antimicrobial peptide market.

Leading companies in the antimicrobial peptide sector are focusing on developing cutting-edge products, such as biodegradable antimicrobial peptides, to tackle antimicrobial resistance and improve treatment effectiveness. Biodegradable antimicrobial peptides are short proteins that decompose into harmless byproducts after neutralizing harmful microorganisms such as bacteria, viruses, and fungi. For instance, in September 2024, Beiersdorf AG, a personal care product manufacturer based in Germany, teamed up with Macro Biologics, a US-based bioengineering firm, to develop these peptides. This partnership aims to create innovative biodegradable antimicrobial solutions, reflecting a trend in the cosmetics industry toward combining advanced biotechnological innovations with sustainability goals.

In December 2023, Invaio Sciences Inc., a US-based biotechnology firm, acquired Peptyde Bio Inc. for an undisclosed sum. This acquisition is intended to bolster Invaio Sciences' capabilities in precision agriculture through advanced peptide-based technologies. Peptyde Bio Inc., also based in the US, specializes in developing novel antimicrobial peptides.

Major companies operating in the anti microbial peptides market are Wuxi AppTec, Sigma Aldrich Chemicals Private Limited, Ipsen S.A., Novozymes A/S, GenScript Biotech, Bachem Holding AG, Basilea Pharmaceutica Ltd., Probiotec Limited, Migenix Inc., Zymeworks Inc., Venatorx Pharmaceuticals Inc., AMPS Biotech Pvt. Ltd., AnaSpec Inc., MediGene AG, Hycult Biotech, Phoenix Biotechnology Inc., Shenzhen Sunsmile Biotechnology Co. Ltd., WatsonBio Sciences, Helix BioMedix, Jiangsu ProteLight Pharmaceutical and Biotechnology Co Ltd.

North America was the largest region in the anti microbial Peptides market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anti microbial peptides market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the anti microbial peptides market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The antimicrobial peptides market consists of sales of natural antimicrobial peptides, synthetic antimicrobial peptides, modified antimicrobial peptides, antimicrobial peptide-based drugs, and antimicrobial peptide-based diagnostic kits. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Anti Microbial Peptides Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on anti microbial peptides market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for anti microbial peptides ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The anti microbial peptides market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Plant Antimicrobial Peptides; Bacterial Antimicrobial Peptides; Animal Antimicrobial Peptides; Insect Antimicrobial Peptides
2) By Ailments: Pneumonia; Hepatitis; Bacterial infections; Human Immunodeficiency Viruses
3) By Route of Administration: Topical; Subcutaneous; Intravenous
4) By Distribution Channel: Hospital; Research Institutes; Specialty Clinic; Pharmacies
5) By End-User: Pharma And Healthcare; Agriculture Industry; Biological Engineering
Subsegments:
1) By Plant Antimicrobial Peptides: Defensins; Thionins; Hevein-Like Peptides; Plant Defensin-Like Peptides; Lipid Transfer Proteins (LTPs)
2) By Bacterial Antimicrobial Peptides: Bacitracin; Nisin; Magainins; Protegrins; Bacillocins
3) By Animal Antimicrobial Peptides: Cathelicidins; Defensins; Histatins; Lactoferrin; Cationic Antimicrobial Peptides (CAMPs)
4) By Insect Antimicrobial Peptides: Cecropins; Defensins; Attacins; Diptericins; Melittin
Companies Mentioned: Wuxi AppTec; Sigma Aldrich Chemicals Private Limited; Ipsen S.A.; Novozymes A/S; GenScript Biotech
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r33395

1. Executive Summary

2. Anti Microbial Peptides Market Characteristics

3. Anti Microbial Peptides Market Trends And Strategies

4. Anti Microbial Peptides Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Anti Microbial Peptides Growth Analysis And Strategic Analysis Framework

5.1. Global Anti Microbial Peptides PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Anti Microbial Peptides Market Growth Rate Analysis
5.4. Global Anti Microbial Peptides Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Anti Microbial Peptides Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Anti Microbial Peptides Total Addressable Market (TAM)

6. Anti Microbial Peptides Market Segmentation

6.1. Global Anti Microbial Peptides Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Plant Antimicrobial Peptides
Bacterial Antimicrobial Peptides
Animal Antimicrobial Peptides
Insect Antimicrobial Peptides
6.2. Global Anti Microbial Peptides Market, Segmentation By Ailments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pneumonia
Hepatitis
Bacterial infections
Human Immunodeficiency Viruses
6.3. Global Anti Microbial Peptides Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Topical
Subcutaneous
Intravenous
6.4. Global Anti Microbial Peptides Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital
Research Institutes
Specialty Clinic
Pharmacies
6.5. Global Anti Microbial Peptides Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pharma And Healthcare
Agriculture Industry
Biological Engineering
6.6. Global Anti Microbial Peptides Market, Sub-Segmentation Of Plant Antimicrobial Peptides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Defensins
Thionins
Hevein-Like Peptides
Plant Defensin-Like Peptides
Lipid Transfer Proteins (LTPs)
6.7. Global Anti Microbial Peptides Market, Sub-Segmentation Of Bacterial Antimicrobial Peptides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Bacitracin
Nisin
Magainins
Protegrins
Bacillocins
6.8. Global Anti Microbial Peptides Market, Sub-Segmentation Of Animal Antimicrobial Peptides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cathelicidins
Defensins
Histatins
Lactoferrin
Cationic Antimicrobial Peptides (CAMPs)
6.9. Global Anti Microbial Peptides Market, Sub-Segmentation Of Insect Antimicrobial Peptides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cecropins
Defensins
Attacins
Diptericins
Melittin

7. Anti Microbial Peptides Market Regional And Country Analysis

7.1. Global Anti Microbial Peptides Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Anti Microbial Peptides Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Anti Microbial Peptides Market

8.1. Asia-Pacific Anti Microbial Peptides Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Anti Microbial Peptides Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Anti Microbial Peptides Market, Segmentation By Ailments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Anti Microbial Peptides Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Anti Microbial Peptides Market

9.1. China Anti Microbial Peptides Market Overview
9.2. China Anti Microbial Peptides Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Anti Microbial Peptides Market, Segmentation By Ailments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Anti Microbial Peptides Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Anti Microbial Peptides Market

10.1. India Anti Microbial Peptides Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Anti Microbial Peptides Market, Segmentation By Ailments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Anti Microbial Peptides Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Anti Microbial Peptides Market

11.1. Japan Anti Microbial Peptides Market Overview
11.2. Japan Anti Microbial Peptides Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Anti Microbial Peptides Market, Segmentation By Ailments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Anti Microbial Peptides Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Anti Microbial Peptides Market

12.1. Australia Anti Microbial Peptides Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Anti Microbial Peptides Market, Segmentation By Ailments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Anti Microbial Peptides Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Anti Microbial Peptides Market

13.1. Indonesia Anti Microbial Peptides Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Anti Microbial Peptides Market, Segmentation By Ailments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Anti Microbial Peptides Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Anti Microbial Peptides Market

14.1. South Korea Anti Microbial Peptides Market Overview
14.2. South Korea Anti Microbial Peptides Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Anti Microbial Peptides Market, Segmentation By Ailments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Anti Microbial Peptides Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Anti Microbial Peptides Market

15.1. Western Europe Anti Microbial Peptides Market Overview
15.2. Western Europe Anti Microbial Peptides Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Anti Microbial Peptides Market, Segmentation By Ailments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Anti Microbial Peptides Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Anti Microbial Peptides Market

16.1. UK Anti Microbial Peptides Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Anti Microbial Peptides Market, Segmentation By Ailments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Anti Microbial Peptides Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Anti Microbial Peptides Market

17.1. Germany Anti Microbial Peptides Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Anti Microbial Peptides Market, Segmentation By Ailments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Anti Microbial Peptides Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Anti Microbial Peptides Market

18.1. France Anti Microbial Peptides Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Anti Microbial Peptides Market, Segmentation By Ailments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Anti Microbial Peptides Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Anti Microbial Peptides Market

19.1. Italy Anti Microbial Peptides Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Anti Microbial Peptides Market, Segmentation By Ailments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Anti Microbial Peptides Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Anti Microbial Peptides Market

20.1. Spain Anti Microbial Peptides Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Anti Microbial Peptides Market, Segmentation By Ailments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Anti Microbial Peptides Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Anti Microbial Peptides Market

21.1. Eastern Europe Anti Microbial Peptides Market Overview
21.2. Eastern Europe Anti Microbial Peptides Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Anti Microbial Peptides Market, Segmentation By Ailments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Anti Microbial Peptides Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Anti Microbial Peptides Market

22.1. Russia Anti Microbial Peptides Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Anti Microbial Peptides Market, Segmentation By Ailments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Anti Microbial Peptides Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Anti Microbial Peptides Market

23.1. North America Anti Microbial Peptides Market Overview
23.2. North America Anti Microbial Peptides Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Anti Microbial Peptides Market, Segmentation By Ailments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Anti Microbial Peptides Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Anti Microbial Peptides Market

24.1. USA Anti Microbial Peptides Market Overview
24.2. USA Anti Microbial Peptides Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Anti Microbial Peptides Market, Segmentation By Ailments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Anti Microbial Peptides Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Anti Microbial Peptides Market

25.1. Canada Anti Microbial Peptides Market Overview
25.2. Canada Anti Microbial Peptides Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Anti Microbial Peptides Market, Segmentation By Ailments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Anti Microbial Peptides Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Anti Microbial Peptides Market

26.1. South America Anti Microbial Peptides Market Overview
26.2. South America Anti Microbial Peptides Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Anti Microbial Peptides Market, Segmentation By Ailments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Anti Microbial Peptides Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Anti Microbial Peptides Market

27.1. Brazil Anti Microbial Peptides Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Anti Microbial Peptides Market, Segmentation By Ailments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Anti Microbial Peptides Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Anti Microbial Peptides Market

28.1. Middle East Anti Microbial Peptides Market Overview
28.2. Middle East Anti Microbial Peptides Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Anti Microbial Peptides Market, Segmentation By Ailments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Anti Microbial Peptides Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Anti Microbial Peptides Market

29.1. Africa Anti Microbial Peptides Market Overview
29.2. Africa Anti Microbial Peptides Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Anti Microbial Peptides Market, Segmentation By Ailments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Anti Microbial Peptides Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Anti Microbial Peptides Market Competitive Landscape And Company Profiles

30.1. Anti Microbial Peptides Market Competitive Landscape
30.2. Anti Microbial Peptides Market Company Profiles
- 30.2.1. Wuxi AppTec Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Sigma Aldrich Chemicals Private Limited Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Ipsen S.A. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Novozymes A/S Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. GenScript Biotech Overview, Products and Services, Strategy and Financial Analysis

31. Anti Microbial Peptides Market Other Major And Innovative Companies

31.1. Bachem Holding AG
31.2. Basilea Pharmaceutica Ltd.
31.3. Probiotec Limited
31.4. Migenix Inc.
31.5. Zymeworks Inc.
31.6. Venatorx Pharmaceuticals Inc.
31.7. AMPS Biotech Pvt. Ltd.
31.8. AnaSpec Inc.
31.9. MediGene AG
31.10. Hycult Biotech
31.11. Phoenix Biotechnology Inc.
31.12. Shenzhen Sunsmile Biotechnology Co. Ltd.
31.13. WatsonBio Sciences
31.14. Helix BioMedix
31.15. Jiangsu ProteLight Pharmaceutical and Biotechnology Co. Ltd.

32. Global Anti Microbial Peptides Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Anti Microbial Peptides Market

34. Recent Developments In The Anti Microbial Peptides Market

35. Anti Microbial Peptides Market High Potential Countries, Segments and Strategies

35.1 Anti Microbial Peptides Market In 2029 - Countries Offering Most New Opportunities
35.2 Anti Microbial Peptides Market In 2029 - Segments Offering Most New Opportunities
35.3 Anti Microbial Peptides Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer
250423_r33395_Anti_Microbial_Peptides_GMR_2025